TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
TCON
Delisted
TCON was delisted on the 27th of June, 2024.
37 hedge funds and large institutions have $34.4M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
29% less capital invested
Capital invested by funds: $48.1M → $34.4M (-$13.7M)
Holders
37
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$181K | |
| 2 | +$103K | |
| 3 | +$55K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$43.8K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$42K |
Top Sellers
| 1 | -$3M | |
| 2 | -$270K | |
| 3 | -$144K | |
| 4 |
AIM
Alambic Investment Management
Belvedere,
California
|
-$71K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$67.1K |